Security record · archived quarter
INVA
Innoviva, Inc. · Healthcare · Biotechnology
13Tracked holders
0Δ holders
9.24MShares held
$175.70MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +10.5% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 246.52K | $5.22M | n/a | −1 |
| Q2 2026 | 104 | +3 | 60.75M | $1.34B | +7 | −5 |
| Q1 2026 | 105 | -1 | 60.91M | $1.40B | +5 | −7 |
| Q4 2025 | 107 | +1 | 64.49M | $1.28B | +2 | n/a |
| Q3 2025 | 19 | 0 | 37.28M | $672.57M | n/a | −1 |
| Q2 2025 | 17 | 0 | 33.81M | $670.62M | n/a | n/a |
| Q1 2025 | 14 | +1 | 14.22M | $254.33M | +1 | n/a |
| Q4 2024 | 13 | -1 | 11.88M | $203.26M | n/a | −1 |
| Q3 2024 | 13 | 0 | 9.24M | $175.70M | n/a | n/a |
| Q2 2024 | 13 | n/a | 8.36M | $134.81M | n/a | n/a |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 4.38M | +0.1% | $83.72M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 1.46M | +0.9% | $26.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | Arrowstreet Capital ✦ | 1.07M | +163.2% | $20.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 658.05K | -0.2% | $12.71M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 497.25K | +318.1% | $9.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 6 | Two Sigma Investments ✦ | 483.81K | -10.4% | $9.34M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Norges Bank ✦ (passive) | 210.01K | -17.7% | $4.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 156.57K | -10.7% | $3.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 136.38K | -33.4% | $2.63M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 76.10K | +235.5% | $1.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 55.71K | +1.1% | $1.08M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 31.99K | +5.0% | $617,669 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 28.17K | -60.3% | $543,886 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 283 holders, 74.79M shares, $1.72B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API